NCT00419653View on ClinicalTrials.gov

Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy

PHASE4TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Schizophrenia
Interventions
DRUG

Amisulpride

DRUG

Olanzapine

DRUG

Haloperidol

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

University of Jena

OTHER